Sign in

CIK 0001636651

  • Non-accelerated filer
  • Smaller reporting company

Ovid Therapeutics Inc.

Sign in to watch
Ticker
OVID
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
465270895
Phone
+1 212-776-4381
Business address
441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY, 10001
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-02-22 Poole Robert Michael Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2023-02-23 Poole Robert Michael Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2022-02-03 Poole Robert Michael Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2021-07-09 Poole Robert Michael Director Grant or award · Stock Option (Right to Buy) +30,000 30,000

Page 1 of 1 · 4 trades